Skip to main content
Clinical Trials/ACTRN12616000470493
ACTRN12616000470493
Completed
Not Applicable

A randomised controlled trial investigating Inhalation of heated, humidified air against placebo in people with the common cold: a feasibility study

Fisher & Paykel Healthcare0 sites30 target enrollmentApril 11, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Common cold
Sponsor
Fisher & Paykel Healthcare
Enrollment
30
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 11, 2016
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Jackson score greater than or equal to 5
  • 2\. Symptoms have been present for less than 48 hours at time of randomisation

Exclusion Criteria

  • 1\. Age \<16 years or \>75 years
  • 2\. Immunocompromised condition:
  • \- Conditions causing immunosuppression e.g. HIV/AIDS, active cancer
  • \- Currently prescribed steroids or other immunosuppressant medication
  • 3\. A diagnosis of asthma, COPD or other significant respiratory conditions
  • 4\. Nasal conditions such as deviated septum, chronic rhinitis, which, in the evaluation by the investigator, could impair nasal breathing.
  • 5\. Use of cold remedies e.g. decongestants/cough linctus/sore throat lozenges within 6 hours of randomisation.
  • 6\. Current use of antibiotics, steroids or inhaled medications.
  • 7\. The investigator believes the participant or their care giver will be unable to safely use the myAIRVO 2 device following discharge
  • 8\. Any other condition which, at the investigator’s discretion, is believed may present a safety risk or impact the feasibility of the study or the study results.

Outcomes

Primary Outcomes

Not specified

Similar Trials